The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Enveric Biosciences on Acquisition of Exclusive License from Diverse Biotech and Value Catalysts Moving Forward

SNNLive spoke with David Johnson, Chairman and CEO of Enveric Biosciences (NASDAQ: ENVB)

Share With

Wednesday, March 17, 2021

   

© 2021 Stock News Now